QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 DermTechRenalytix AIRadNetProgenityCentogene
SymbolNASDAQ:DMTKNASDAQ:RNLXNASDAQ:RDNTNASDAQ:PROGNASDAQ:CNTG
Price Information
Current Price$75.73$24.79$19.55$5.87$12.08
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.50.91.52.21.2
Analysis Score1.51.32.53.33.5
Community Score3.02.52.63.52.5
Dividend Score0.00.00.00.00.0
Ownership Score2.50.01.73.30.0
Earnings & Valuation Score0.60.60.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$50.25$22.00$22.50$9.80$20.00
% Upside from Price Target-33.65% downside-11.25% downside15.09% upside66.95% upside65.56% upside
Trade Information
Market Cap$1.48 billion$892.81 million$1.01 billion$320.63 million$239.92 million
Beta0.99N/A1.52N/A-2.25
Average Volume1,511,272126,236183,223624,98378,959
Sales & Book Value
Annual Revenue$3.36 millionN/A$1.15 billionN/A$54.64 million
Price / Sales441.65N/A0.87N/A4.39
CashflowN/AN/A$3.06 per shareN/AN/A
Price / CashN/AN/A6.38N/AN/A
Book Value$1.01 per share$0.45 per share$4.63 per shareN/A$3.32 per share
Price / Book74.98N/A4.22N/A3.64
Profitability
Net Income$-19,690,000.00$-9,840,000.00$14.76 millionN/A$-23,360,000.00
EPS($2.81)($0.16)$0.29N/A($1.46)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/A1,239.5042.50N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-577.75%N/A-0.98%N/AN/A
Return on Equity (ROE)-65.00%N/A-2.72%N/AN/A
Return on Assets (ROA)-58.37%N/A-0.37%N/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A2.55%N/A0.01%
Current Ratio13.31%22.75%0.69%1.07%1.92%
Quick Ratio13.28%22.75%0.69%0.95%1.71%
Ownership Information
Institutional Ownership Percentage51.35%13.61%67.46%17.08%15.80%
Insider Ownership Percentage16.48%N/A5.77%80.60%N/A
Miscellaneous
Employees6088,498702440
Shares Outstanding19.60 million36.02 million51.64 million54.62 million19.86 million
Next Earnings Date3/4/2021 (Confirmed)3/2/2021 (Confirmed)3/8/2021 (Confirmed)3/1/2021 (Estimated)4/22/2021 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.